Education
About Us
Working with TipRanks
Follow Us
Koninklijke Philips N.V. (DE:PHIA)
NYSE:PHIA
PHIA Stock Chart & Stats
€24.00
€0.00(0.00%)
At close: 4:00 PM EDT
€24.00
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€18.50 - €27.60
Previous CloseN/A
Volume59.00
Average Volume (3M)20.00
Market Cap
€24.86B
Enterprise Value€30.59B
Total Cash (Recent Filing)€2.79B
Total Debt (Recent Filing)€8.09B
Price to Earnings (P/E)27.5
Beta0.71
Next Earnings
May 06, 2026EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.60
Shares Outstanding962,920,100
10 Day Avg. Volume20
30 Day Avg. Volume20
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.02
Price to Sales (P/S)1.24
P/FCF Ratio24.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Innovation & M&APhilips’ steady rollout of platform innovations (helium-free 3.0T MRI, AI CT, LumiGuide) plus targeted M&A (SpectraWAVE) strengthens its differentiated product portfolio. These moves broaden clinical offerings, deepen addressable markets in imaging and coronary intervention, and support sustainable mix-driven margin expansion and long-term service/software revenue growth.
Productivity & Cost ProgramsLarge, multi-year productivity delivery materially lowers structural cost base, improving operating leverage. Sustained savings provide durable margin support to offset tariffs and fund R&D and growth initiatives, increasing resilience of adjusted EBITDA margins and enabling reinvestment without sacrificing profitability over the medium term.
Order Momentum & Margin ImprovementStronger order intake and visible order book growth signal durable demand and revenue visibility heading into 2026. Concurrent margin expansion reflects better mix, productivity and pricing power; together these trends support sustainable operating profitability and make targets for mid‑term margin improvement more credible.
Bears Say
Respironics Legal & Recall RiskActive regulatory actions and large settlement payments create enduring legal, compliance and cash‑flow uncertainty. These matters can require ongoing remediation spend, constrain capital allocation, distract management, and risk further liabilities or operational restrictions that could depress profitability and cash generation for multiple quarters or years.
Tariff HeadwindsMaterial, recurring tariff exposure meaningfully increases costs and pressures gross margins absent full mitigation. Over the medium term tariffs force pricing, localization and supply‑chain changes that can erode competitiveness, require sustained productivity offsets, and cap margin upside during uncertain trade policy environments.
Volatile Cash GenerationFree cash flow has shown sharp swings due to legal settlements, insurance receipts and working‑capital variability. This volatility reduces predictability for reinvestment, debt reduction and dividends, and elevates refinancing or liquidity risk if adverse events recur, limiting financial flexibility until cash conversion stabilizes.
Koninklijke Philips News
PHIA FAQ
What was Koninklijke Philips N.V.’s price range in the past 12 months?
Koninklijke Philips N.V. lowest stock price was €18.50 and its highest was €27.60 in the past 12 months.
What is Koninklijke Philips N.V.’s market cap?
Koninklijke Philips N.V.’s market cap is €24.86B.
When is Koninklijke Philips N.V.’s upcoming earnings report date?
Koninklijke Philips N.V.’s upcoming earnings report date is May 06, 2026 which is in 76 days.
How were Koninklijke Philips N.V.’s earnings last quarter?
Koninklijke Philips N.V. released its earnings results on Feb 10, 2026. The company reported €0.604 earnings per share for the quarter, beating the consensus estimate of €0.477 by €0.127.
Is Koninklijke Philips N.V. overvalued?
According to Wall Street analysts Koninklijke Philips N.V.’s price is currently Overvalued.
Does Koninklijke Philips N.V. pay dividends?
Koninklijke Philips N.V. does not currently pay dividends.
What is Koninklijke Philips N.V.’s EPS estimate?
Koninklijke Philips N.V.’s EPS estimate is 0.21.
How many shares outstanding does Koninklijke Philips N.V. have?
Koninklijke Philips N.V. has 962,920,100 shares outstanding.
What happened to Koninklijke Philips N.V.’s price movement after its last earnings report?
Koninklijke Philips N.V. reported an EPS of €0.604 in its last earnings report, beating expectations of €0.477. Following the earnings report the stock price went up 13.115%.
Which hedge fund is a major shareholder of Koninklijke Philips N.V.?
Currently, no hedge funds are holding shares in DE:PHIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Koninklijke Philips Stock Smart Score
Company Description
Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
PHIA Company Deck
PHIA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a broadly positive operational and financial performance: strong Q4 order intake and sales acceleration, substantial margin expansion, robust Personal Health and Connected Care momentum, significant productivity delivered and an active innovation pipeline. These positives are balanced by tangible near‑term headwinds — notably tariffs (annualized impact in 2026), ongoing Respironics‑related legal and regulatory matters, China tender dynamics, and some D&T margin pressure and Q1 phasing risk. Management has mitigations in place (productivity programs, pricing, localization) and a clear guide for 2026 (3%–4.5% sales growth; 12.5%–13% EBITDA margin), which supports confidence in execution despite the known risks.View all DE:PHIA earnings summariesTechnical Analysis
Options Prices
Currently, No data available
---